nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Frailty Index predicts 10-year fracture risk in adults age 25 years and older: results from the Canadian Multicentre Osteoporosis Study (CaMos)
|
Kennedy, C. C. |
|
2014 |
25 |
12 |
p. 2825-2832 |
artikel |
2 |
Association of stressful life events with accelerated bone loss in older men: the osteoporotic fractures in men (MrOS) study
|
Fink, H. A. |
|
2014 |
25 |
12 |
p. 2833-2839 |
artikel |
3 |
Associations of polymorphisms in the SOST gene and bone mineral density in postmenopausal Chinese Women
|
Zhang, H. |
|
2014 |
25 |
12 |
p. 2797-2803 |
artikel |
4 |
A trabecular plate-like phenotype is overrepresented in Chinese-American versus Caucasian women
|
Walker, M. D. |
|
2014 |
25 |
12 |
p. 2787-2795 |
artikel |
5 |
Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy
|
Hofstetter, B. |
|
2014 |
25 |
12 |
p. 2709-2719 |
artikel |
6 |
Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients
|
Ebina, K. |
|
2014 |
25 |
12 |
p. 2755-2765 |
artikel |
7 |
Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
|
Paggiosi, M. A. |
|
2014 |
25 |
12 |
p. 2729-2741 |
artikel |
8 |
Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures
|
Nelson, S. D. |
|
2014 |
25 |
12 |
p. 2701-2707 |
artikel |
9 |
Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider
|
Kyvernitakis, I. |
|
2014 |
25 |
12 |
p. 2721-2728 |
artikel |
10 |
Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
|
Leslie, W. D. |
|
2014 |
25 |
12 |
p. 2817-2824 |
artikel |
11 |
Erratum to: Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: is treatment with bisphosphonates an option?
|
Lubwama, R. |
|
2014 |
25 |
12 |
p. 2841 |
artikel |
12 |
Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats
|
Jia, H. B. |
|
2014 |
25 |
12 |
p. 2743-2754 |
artikel |
13 |
Incidence and risk factors for osteoporotic vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing & Health (SPAH) Study
|
Domiciano, D. S. |
|
2014 |
25 |
12 |
p. 2805-2815 |
artikel |
14 |
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
|
Sapir-Koren, R. |
|
2014 |
25 |
12 |
p. 2685-2700 |
artikel |
15 |
Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA
|
Wilk, A. |
|
2014 |
25 |
12 |
p. 2777-2786 |
artikel |
16 |
Vitamin D and skeletal health in infancy and childhood
|
Moon, R. J. |
|
2014 |
25 |
12 |
p. 2673-2684 |
artikel |
17 |
Vitamin D insufficiency over 5 years is associated with increased fracture risk—an observational cohort study of elderly women
|
Buchebner, D. |
|
2014 |
25 |
12 |
p. 2767-2775 |
artikel |